Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

242
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
242
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

473
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
473
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

672
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
672
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

806
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
806
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

785
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
785
Drug Therapy01:28

Drug Therapy

83
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allosteric Inhibition Modulates SHP2 Diffusion Behavior from Rotational to Translational via C-SH2 Domain Stabilization.

Journal of chemical information and modeling·2026
Same author

A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC.

Science advances·2026
Same author

Gut microbiota-derived lysine phenylacetylation impairs mitochondrial function and is alleviated by SIRT3.

Cell metabolism·2026
Same author

Proteomics-Driven Strategies for Proximity-Inducing Drug Discovery.

Angewandte Chemie (International ed. in English)·2026
Same author

MAFF regulates ferroptotic sensitivity through iron homeostasis and fatty acid synthesis.

Cell death & disease·2026
Same author

Correction: Visualizing glutathione levels in adipose tissue: a CBD aryl ether thiolysis-activated ESIPT probe for obesity research.

Chemical communications (Cambridge, England)·2026

Related Experiment Video

Updated: Aug 18, 2025

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
07:38

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s

Published on: September 25, 2017

10.2K

The magic bullet: Niclosamide.

Haowen Jiang1, Albert M Li1,2, Jiangbin Ye1,2,3

  • 1Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States.

Frontiers in Oncology
|December 8, 2022
PubMed
Summary

Niclosamide, an anti-tapeworm drug, shows broad anti-cancer effects by inhibiting multiple cancer pathways and activating tumor suppressors. This drug is being investigated as a potential cancer

Keywords:
anti-tumor effectepigeneticsmagic bulletmetabolismmitochondrial uncouplerniclosamideoncogenic pathwaystumor suppressors

More Related Videos

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
11:00

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

Published on: August 31, 2015

8.4K
Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity
08:28

Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity

Published on: August 25, 2019

13.7K

Related Experiment Videos

Last Updated: Aug 18, 2025

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
07:38

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s

Published on: September 25, 2017

10.2K
Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
11:00

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

Published on: August 31, 2015

8.4K
Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity
08:28

Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity

Published on: August 25, 2019

13.7K

Area of Science:

  • Oncology
  • Drug Discovery
  • Cancer Biology

Background:

  • The concept of a 'magic bullet' drug for cancer remains elusive with current therapies.
  • Existing cancer treatments like chemotherapy and radiation have limitations in specificity and efficacy.
  • Niclosamide, an FDA-approved anthelmintic, exhibits promising broad-spectrum anti-cancer properties.

Purpose of the Study:

  • To review the functions and mechanisms of niclosamide as a potential cancer 'magic bullet'.
  • To summarize niclosamide's multi-targeted inhibition of oncogenic pathways and activation of tumor suppressors.
  • To discuss niclosamide's potential role in improving cancer immunotherapy and its clinical applications.

Main Methods:

  • Review of pre-clinical studies on niclosamide's anti-cancer activity.
  • Analysis of niclosamide's effects on multiple oncogenic and tumor suppressor signaling pathways.
  • Investigation of niclosamide's impact on cellular metabolism and epigenetic remodeling.

Main Results:

  • Niclosamide inhibits key cancer pathways including Wnt/β-catenin, Ras, Stat3, Notch, E2F-Myc, NF-κB, and mTOR.
  • Niclosamide activates tumor suppressor pathways such as p53, PP2A, and AMPK.
  • Niclosamide ethanolamine (NEN) reprograms cellular metabolism, remodels epigenetics, and promotes differentiation.

Conclusions:

  • Niclosamide demonstrates significant potential as a 'magic bullet' cancer therapy due to its broad efficacy and safety profile.
  • Niclosamide's ability to target multiple pathways and modulate the tumor microenvironment offers a novel therapeutic strategy.
  • Ongoing clinical trials are evaluating niclosamide's therapeutic effects in cancer patients, highlighting its promising future in oncology.